Some versions of pregabalin are low in stock.
Pfizer’s version of pregabalin – called Lyrica – is low in stock. This applies to both the liquid and capsules in all doses. We have been told the stock issues with the liquid version are because of a problem with the bottle closure. Pfizer are not expecting any new stock until at least July 2017.
TEVA’s version of pregabalin is also very low in stock in all doses. TEVA do not know when they will have more in stock.
Other versions of pregabalin marketed by Actavis (under the brand name Lecaent) and Consilient (under the brand name Rewisca) currently have no supply problems.
If you have any concerns about this speak to your doctor or epilepsy specialist nurse.